Suppr超能文献

幽门螺杆菌感染对胃及胃食管交界部癌切除术后结局的影响。

Effect of Helicobacter pylori infection on outcomes in resected gastric and gastroesophageal junction cancer.

作者信息

Kolb Jennifer M, Ozbek Umut, Harpaz Noam, Holcombe Randall F, Ang Celina

机构信息

Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

出版信息

J Gastrointest Oncol. 2017 Jun;8(3):583-588. doi: 10.21037/jgo.2017.01.22.

Abstract

BACKGROUND

Helicobacter pylori (H pylori) infection is a known risk factor for gastric cancer (GC) and has been linked with gastroesophageal junction (GEJ) cancer. Studies examining the relationship between H. pylori infection, GC characteristics and prognosis are limited and have yielded conflicting results. We report on the clinicopathologic characteristics and oncologic outcomes of gastric and GEJ cancer patients with and without a history of H. pylori treated at our institution.

METHODS

We retrospectively reviewed the medical records of patients over the age of 18 years who underwent curative resection for GEJ and GC at Mount Sinai Hospital between 2007 and 2012 who had histopathologic documentation of the presence or absence of H pylori infection. Demographic, clinical, pathologic, treatment characteristics and outcomes including recurrence-free survival (RFS) and overall survival (OS) were compared.

RESULTS

Ninety-five patients were identified. The majority of patients were male (61%), white (36%) or Asian (34%), with median age at diagnosis 64. Tumors were stage I (51%), stage II (23%), stage III (25%), and stage IV (1%). H pylori infection status was documented at the time of cancer diagnosis in 89 (94%) patients, and following cancer diagnosis and treatment in 6 (6%) patients. Younger age at diagnosis, Asian race and Lauren histologic classification were associated with H Pylori infection. H pylori positive patients exhibited higher 5-year OS and 5-year RFS compared to H pylori negative patients, though the difference was not statistically significant in either univariate or multivariate analyses.

CONCLUSIONS

In this retrospective series of predominantly early stage GC and GEJ cancers, H. pylori positive patients were significantly younger at cancer diagnosis and were more frequently Asian compared to H. pylori negative patients. Other demographic and histologic classifications except for Lauren histologic classification were similar between the two groups. H pylori positive patients appeared to have improved outcomes compared to H. pylori negative patients.

摘要

背景

幽门螺杆菌(H pylori)感染是已知的胃癌(GC)风险因素,且与胃食管交界(GEJ)癌有关。研究幽门螺杆菌感染、胃癌特征与预后之间关系的研究有限,结果也相互矛盾。我们报告了在我们机构接受治疗的有或无幽门螺杆菌感染史的胃癌和胃食管交界癌患者的临床病理特征和肿瘤学结局。

方法

我们回顾性分析了2007年至2012年在西奈山医院接受GEJ和GC根治性切除术、年龄在18岁以上且有幽门螺杆菌感染组织病理学记录的患者的病历。比较了人口统计学、临床、病理、治疗特征及包括无复发生存期(RFS)和总生存期(OS)在内的结局。

结果

共确定了95例患者。大多数患者为男性(61%),白人(36%)或亚洲人(34%),诊断时的中位年龄为64岁。肿瘤分期为I期(51%)、II期(23%)、III期(25%)和IV期(1%)。89例(94%)患者在癌症诊断时记录了幽门螺杆菌感染状态,6例(6%)患者在癌症诊断和治疗后记录。诊断时年龄较小、亚洲种族和劳伦组织学分类与幽门螺杆菌感染相关。与幽门螺杆菌阴性患者相比,幽门螺杆菌阳性患者的5年总生存期和5年无复发生存期更高,尽管在单因素或多因素分析中差异均无统计学意义。

结论

在这个主要为早期胃癌和胃食管交界癌的回顾性系列研究中,与幽门螺杆菌阴性患者相比,幽门螺杆菌阳性患者在癌症诊断时明显更年轻,且更常见为亚洲人。两组之间除劳伦组织学分类外的其他人口统计学和组织学分类相似。与幽门螺杆菌阴性患者相比,幽门螺杆菌阳性患者似乎预后更好。

相似文献

1
Effect of Helicobacter pylori infection on outcomes in resected gastric and gastroesophageal junction cancer.
J Gastrointest Oncol. 2017 Jun;8(3):583-588. doi: 10.21037/jgo.2017.01.22.
3
Preoperative Helicobacter pylori Infection is Associated with Increased Survival After Resection of Gastric Adenocarcinoma.
Ann Surg Oncol. 2016 Apr;23(4):1225-33. doi: 10.1245/s10434-015-4953-x. Epub 2015 Nov 9.
4
Effect of Helicobacter pylori Eradication on Long-Term Survival after Distal Gastrectomy for Gastric Cancer.
Cancer Res Treat. 2016 Jul;48(3):1020-9. doi: 10.4143/crt.2015.264. Epub 2015 Nov 17.
6
Helicobacter pylori-negative gastric cancer in South Korea: incidence and clinicopathologic characteristics.
Helicobacter. 2011 Oct;16(5):382-8. doi: 10.1111/j.1523-5378.2011.00859.x.
8
Helicobacter pylori is not associated with the manifestations of gastroesophageal reflux disease.
Arch Surg. 1999 Jul;134(7):722-6. doi: 10.1001/archsurg.134.7.722.
9
Characteristics of gastric cancer in peptic ulcer patients with Helicobacter pylori infection.
World J Gastroenterol. 2015 Apr 28;21(16):4954-60. doi: 10.3748/wjg.v21.i16.4954.
10
Pathology of the gastroesophageal junction.
Semin Diagn Pathol. 2005 Nov;22(4):256-65. doi: 10.1053/j.semdp.2006.04.007.

引用本文的文献

1
Chromosomal Instability in Gastric Cancer: Role in Tumor Development, Progression, and Therapy.
Int J Mol Sci. 2023 Nov 30;24(23):16961. doi: 10.3390/ijms242316961.
2
Prognostic effects of the gastric mucosal microbiota in gastric cancer.
Cancer Sci. 2023 Mar;114(3):1075-1085. doi: 10.1111/cas.15661. Epub 2022 Nov 29.
4
5
Activation of CD3 T cells by Helicobacter pylori DNA vaccines in potential immunotherapy of gastric carcinoma.
Cancer Biol Ther. 2019;20(6):866-876. doi: 10.1080/15384047.2019.1579957. Epub 2019 Feb 20.
6
Polyphenols as Promising Drugs against Main Breast Cancer Signatures.
Antioxidants (Basel). 2017 Nov 7;6(4):88. doi: 10.3390/antiox6040088.

本文引用的文献

1
[Meta-analysis on relationship between Helicobacter pylori infection and esophagogastric junction adenocarcinoma].
Zhonghua Liu Xing Bing Xue Za Zhi. 2016 Mar;37(3):418-24. doi: 10.3760/cma.j.issn.0254-6450.2016.03.027.
2
Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication.
Gastrointest Endosc. 2016 Oct;84(4):618-24. doi: 10.1016/j.gie.2016.03.791. Epub 2016 Mar 16.
3
Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis.
Gastroenterology. 2016 May;150(5):1113-1124.e5. doi: 10.1053/j.gastro.2016.01.028. Epub 2016 Feb 2.
4
Helicobacter pylori in gastric carcinogenesis.
World J Gastrointest Oncol. 2015 Dec 15;7(12):455-65. doi: 10.4251/wjgo.v7.i12.455.
5
Viruses, Other Pathogenic Microorganisms and Esophageal Cancer.
Gastrointest Tumors. 2015 May;2(1):2-13. doi: 10.1159/000380897. Epub 2015 Apr 8.
6
Preoperative Helicobacter pylori Infection is Associated with Increased Survival After Resection of Gastric Adenocarcinoma.
Ann Surg Oncol. 2016 Apr;23(4):1225-33. doi: 10.1245/s10434-015-4953-x. Epub 2015 Nov 9.
7
Helicobacter pylori eradication for the prevention of gastric neoplasia.
Cochrane Database Syst Rev. 2015 Jul 22;2015(7):CD005583. doi: 10.1002/14651858.CD005583.pub2.
8
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.
N Engl J Med. 2015 Jun 25;372(26):2509-20. doi: 10.1056/NEJMoa1500596. Epub 2015 May 30.
9
Prognostic significance of lymphovascular invasion in node-negative gastric cancer.
World J Surg. 2015 Mar;39(3):732-9. doi: 10.1007/s00268-014-2846-y.
10
Epidemiology of Helicobacter pylori infection.
Helicobacter. 2014 Sep;19 Suppl 1:1-5. doi: 10.1111/hel.12165.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验